Jan 24, 2020

Vaccination Programs for Adults in Europe, 2019

Vaccines
Dimitrios C CassimosHelena C Maltezou

Abstract

While all European countries implement vaccination programs for children, there are gaps in terms of vaccination programs for adults. We studied the 2019 vaccination policies for adults in 42 European countries. Vaccination programs for adults were in place in all countries. However, there were considerable differences between countries in terms of number of vaccinations, target populations and frame of implementation (recommended or mandatory vaccinations). In particular the following vaccination policies were in place: influenza (42 countries), tetanus (31), diphtheria (30), pneumococcus (29), hepatitis B (20), pertussis (18), measles (14), human papilloma virus (14), meningococcus tetravalent A,C,W,Y (14), rubella (13), hepatitis A (11), mumps (11), poliomyelitis (10), herpes zoster (9), varicella (8), tick-born encephalitis (8), meningococcus B (6), rabies (6), Haemophilusinfluenzae type b (5), tuberculosis (3), typhoid fever (3), meningococcus C (2), and yellow fever (1). Seventeen countries implement mandatory vaccinations, mainly against diphtheria, tetanus and hepatitis B. There are significant differences in vaccination programs for adults in Europe. Routine vaccination programs for adults need to be strengthened. A co...Continue Reading

  • References25
  • Citations

References

  • References25
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Corynebacterium diphtheriae
Vaccination
Hepatitis B
Poliomyelitis
Glutamate receptor type B
Tick-Borne Encephalitis
Screening for Yellow Fever
Typhoid Fever
Streptococcus pneumoniae
Immunization Programs

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Vaccine
Helena C MaltezouVaccination Policies for HCP in Europe Study Group
Cleveland Clinic Journal of Medicine
J Long, K Kyllonen
Therapeutische Umschau. Revue thérapeutique
F Hofmann
© 2020 Meta ULC. All rights reserved